Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis
2023-04-04 20:50
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects
2023-04-04 20:00
Latest Updates of 6 Viva's Portfolio Companies
2023-04-04 19:39
Cambrex Opens New Stability Storage Facility in Belgium
2023-04-04 15:00
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer
2023-04-04 10:00
BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award
2023-04-04 08:30
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects
2023-04-04 08:00
GC Cell and New Management Embarking on a New Chapter
2023-04-03 16:47
Harbour BioMed Reports Full Year 2022 Financial Results
2023-04-03 15:10
The World's Second Approved Biosimilars of Denosumab (MAILISHU)
2023-04-03 13:44
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner
2023-04-01 10:00
Henlius 2022 Annual Results: Significant Achievements in Commercialisation, Surged to RMB3.2 Billion in Revenues
2023-04-01 00:06
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022
2023-03-31 18:30
Boao Forum for Asia Enters the Healthcare Sector
2023-03-31 10:00
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
2023-03-31 10:00
Genscript Biotech Reports 2022 Annual Results*
2023-03-31 08:40
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022
2023-03-31 07:30
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress
2023-03-31 00:33
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference
2023-03-30 21:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization
2023-03-30 20:51
1
116
117
118
119
120
416